Detalles de la búsqueda
1.
The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance.
FASEB J;
19(11): 1567-9, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16009704
2.
Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum.
J Neurosci;
22(5): 1929-36, 2002 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11880523
3.
Non-peptide vasopressin V1b receptor antagonists as potential drugs for the treatment of stress-related disorders.
Curr Pharm Des;
11(12): 1549-59, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15892661
4.
Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
Neuropsychopharmacology;
30(1): 145-55, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15292905
5.
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Neuropsychopharmacology;
30(11): 1963-85, 2005 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15956994
6.
Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Neuropsychopharmacology;
29(5): 911-20, 2004 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-14694354
7.
SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity.
Neuropsychopharmacology;
28(11): 1889-902, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-12902993
8.
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
Neuropsychopharmacology;
28(12): 2064-76, 2003 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12902994
9.
Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia.
Brain Res;
953(1-2): 63-72, 2002 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-12384239
10.
Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice.
Neurosci Lett;
343(3): 216-8, 2003 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-12770700
11.
The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Naunyn Schmiedebergs Arch Pharmacol;
365(6): 427-33, 2002 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-12070755
12.
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.
Hepatology;
46(1): 122-9, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17526015
13.
Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals.
Alcohol Alcohol;
39(6): 486-92, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15466898
14.
The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
J Neurochem;
87(2): 487-96, 2003 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-14511126
15.
Direct and indirect interactions between cannabinoid CB1 receptor and group II metabotropic glutamate receptor signalling in layer V pyramidal neurons from the rat prefrontal cortex.
Eur J Neurosci;
17(5): 981-90, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12653974
16.
Specific involvement of neurotensin type 1 receptor in the neurotensin-mediated in vivo dopamine efflux using knock-out mice.
J Neurochem;
89(1): 1-6, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15030383
17.
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice.
Am J Physiol Regul Integr Comp Physiol;
284(2): R345-53, 2003 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-12399252
18.
Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801.
Synapse;
43(1): 62-9, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11746734
19.
Expression profile and up-regulation of PRAX-1 mRNA by antidepressant treatment in the rat brain.
Mol Pharmacol;
62(6): 1314-20, 2002 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-12435798
20.
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
Proc Natl Acad Sci U S A;
99(9): 6370-5, 2002 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-11959912